Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

FDA-Catalyst-Using FDA's Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial.

Cocoros NM, Pokorney SD, Haynes K, Garcia C, Al-Khalidi HR, Al-Khatib SM, Archdeacon P, Goldsack JC, Harkins T, Lin ND, Martin D, McCall D, Nair V, Parlett L, Temple R, McMahill-Walraven C, Granger CB, Platt R.

Clin Trials. 2018 Nov 16:1740774518812776. doi: 10.1177/1740774518812776. [Epub ahead of print]

PMID:
30445835
2.

Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study.

Pokorney SD, Bloom D, Granger CB, Thomas KL, Al-Khatib SM, Roettig ML, Anderson J Jr, Heflin MT, Granger BB.

Eur J Cardiovasc Nurs. 2018 Nov 12:1474515118812252. doi: 10.1177/1474515118812252. [Epub ahead of print]

PMID:
30418049
3.

Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review.

Lowenstern A, Al-Khatib SM, Sharan L, Chatterjee R, LaPointe NMA, Shah B, Borre ED, Raitz G, Goode A, Yapa R, Davis JK, Lallinger K, Schmidt R, Kosinski AS, Sanders GD.

Ann Intern Med. 2018 Oct 30. doi: 10.7326/M18-1523. [Epub ahead of print]

PMID:
30383133
4.

Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review.

Borre ED, Goode A, Raitz G, Shah B, Lowenstern A, Chatterjee R, Sharan L, Allen LaPointe NM, Yapa R, Davis JK, Lallinger K, Schmidt R, Kosinski A, Al-Khatib SM, Sanders GD.

Thromb Haemost. 2018 Oct 30. doi: 10.1055/s-0038-1675400. [Epub ahead of print]

PMID:
30376678
5.

Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.

Luo N, Xu H, Jneid H, Fonarow GC, Lopes RD, Piccini JP, Curtis AB, Russo AM, Lewis WR, Matsouaka RA, Granger CB, Mentz RJ, Al-Khatib SM.

Circ Heart Fail. 2018 Oct;11(10):e005356. doi: 10.1161/CIRCHEARTFAILURE.118.005356.

PMID:
30354398
6.

The changing epidemiology of ventricular arrhythmias and sudden cardiac death: Is it a reality?

Al-Khatib SM, Granger CB.

Heart Rhythm. 2018 Oct 4. pii: S1547-5271(18)31014-2. doi: 10.1016/j.hrthm.2018.09.031. [Epub ahead of print] No abstract available.

PMID:
30291915
7.

Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis.

Zeitler EP, Sanders GD, Singh K, Greenfield RA, Gillis AM, Wilkoff BL, Piccini JP, Al-Khatib SM.

Europace. 2018 Oct 1;20(10):1621-1629. doi: 10.1093/europace/euy183.

PMID:
30137296
8.

The Association of Duration of participation in get with the guidelines-resuscitation with quality of Care for in-Hospital Cardiac Arrest.

Starks MA, Dai D, Nichol G, Al-Khatib SM, Chan P, Bradley SM, Peterson ED; American Heart Association's Get With the Guidelines-Resuscitation Investigators.

Am Heart J. 2018 Oct;204:156-162. doi: 10.1016/j.ahj.2018.04.018. Epub 2018 May 5.

PMID:
30121017
9.

Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies.

Al-Khatib SM, Stevenson WG.

JAMA Cardiol. 2018 Aug 1;3(8):775-776. doi: 10.1001/jamacardio.2018.1116. No abstract available.

PMID:
29955839
10.

The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients.

Friedman DJ, Fudim M, Overton R, Shaw LK, Patel D, Pokorney SD, Velazquez EJ, Al-Khatib SM.

Am Heart J. 2018 Jul;201:17-24. doi: 10.1016/j.ahj.2018.03.017. Epub 2018 Apr 4.

PMID:
29910051
11.

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.

Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L.

Circulation. 2018 Oct 16;138(16):1666-1676. doi: 10.1161/CIRCULATIONAHA.118.034125.

PMID:
29871978
12.

Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.

Sharma A, Al-Khatib SM, Ezekowitz JA, Cooper LB, Fordyce CB, Michael Felker G, Bardy GH, Poole JE, Thomas Bigger J, Buxton AE, Moss AJ, Friedman DJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Peterson ED, Inoue LYT, Sanders GD.

Eur J Heart Fail. 2018 Jun;20(6):1031-1038. doi: 10.1002/ejhf.1192. Epub 2018 May 15.

PMID:
29761861
13.

Temporal Trends in and Factors Associated With Use of Single- Versus Dual-Coil Implantable Cardioverter-Defibrillator Leads: Data From the NCDR ICD Registry.

Pokorney SD, Parzynski CS, Daubert JP, Hegland DD, Varosy PD, Curtis JP, Al-Khatib SM.

JACC Clin Electrophysiol. 2017 Jun;3(6):612-619. doi: 10.1016/j.jacep.2016.11.014. Epub 2017 Apr 26.

14.

Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry.

Khazanie P, Hellkamp AS, Fonarow GC, Curtis LH, Al-Khatib SM, Hernandez AF.

Am Heart J. 2018 Apr;198:123-128. doi: 10.1016/j.ahj.2017.12.020. Epub 2018 Jan 9.

PMID:
29653633
15.

Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Related to Ischemic and Nonischemic Cardiomyopathy.

Al-Khatib SM, Stevenson WG.

JAMA Cardiol. 2018 Jun 1;3(6):541-542. doi: 10.1001/jamacardio.2018.0016. No abstract available.

PMID:
29641810
16.

Dofetilide dose reductions and discontinuations in women compared with men.

Pokorney SD, Yen DC, Campbell KB, Allen LaPointe NM, Sheng S, Thomas L, Bahnson TD, Daubert JP, Picini JP, Jackson KP, Thomas KL, Al-Khatib SM.

Heart Rhythm. 2018 Apr;15(4):478-484. doi: 10.1016/j.hrthm.2018.01.027.

PMID:
29605013
17.

Left Atrial Appendage Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A Meta-Analysis.

Friedman DJ, Black-Maier EW, Barnett AS, Pokorney SD, Al-Khatib SM, Jackson KP, Bahnson TD, Ellis CR, Atwater BD, Lewis RK, Piccini JP.

JACC Clin Electrophysiol. 2018 Jan;4(1):112-120. doi: 10.1016/j.jacep.2017.07.007. Epub 2017 Sep 13.

PMID:
29600775
18.

MY APPROACH to the risk stratification of patients for sudden cardiac death.

Al-Khatib SM.

Trends Cardiovasc Med. 2018 May;28(4):308-309. doi: 10.1016/j.tcm.2017.11.007. Epub 2017 Dec 6. No abstract available.

PMID:
29551578
19.

Digoxin and Mortality in Patients With Atrial Fibrillation.

Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators.

J Am Coll Cardiol. 2018 Mar 13;71(10):1063-1074. doi: 10.1016/j.jacc.2017.12.060.

PMID:
29519345
20.

Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry.

Friedman DJ, Parzynski CS, Heist EK, Russo AM, Akar JG, Freeman JV, Curtis JP, Al-Khatib SM.

Circulation. 2018 Jun 5;137(23):2463-2477. doi: 10.1161/CIRCULATIONAHA.117.032167. Epub 2018 Feb 20.

PMID:
29463509
21.

When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion?

Al-Khatib SM, Friedman DJ, Sanders GD.

Card Electrophysiol Clin. 2018 Mar;10(1):137-144. doi: 10.1016/j.ccep.2017.11.014. Review.

PMID:
29428135
22.

Training cardiovascular outcomes researchers: A survey of mentees and mentors to identify critical training gaps and needs.

Khazanie P, Al-Khatib SM, Wang TY, Crowley MJ, Kressin NR, Krumholz HM, Kiefe CI, Wells BL, O'Brien SM, Peterson ED, Sanders GD.

Am Heart J. 2018 Feb;196:170-177. doi: 10.1016/j.ahj.2017.07.022. Epub 2017 Sep 19.

PMID:
29421010
23.

How well does early-career investigators' cardiovascular outcomes research training align with funded outcomes research?

Crowley MJ, Al-Khatib SM, Wang TY, Khazanie P, Kressin NR, Krumholz HM, Kiefe CI, Wells BL, O'Brien SM, Peterson ED, Sanders GD.

Am Heart J. 2018 Feb;196:163-169. doi: 10.1016/j.ahj.2017.09.008. Epub 2017 Sep 18.

PMID:
29421009
24.

Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.

Pokorney SD, Al-Khatib SM, Sun JL, Schulte P, O'Connor CM, Teerlink JR, Armstrong PW, Ezekowitz JA, Starling RC, Voors AA, Velazquez EJ, Hernandez AF, Mentz RJ.

Eur J Heart Fail. 2018 Mar;20(3):525-532. doi: 10.1002/ejhf.1078. Epub 2017 Dec 20.

PMID:
29266564
25.

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.

Black-Maier E, Ren X, Steinberg BA, Green CL, Barnett AS, Rosa NS, Al-Khatib SM, Atwater BD, Daubert JP, Frazier-Mills C, Grant AO, Hegland DD, Jackson KP, Jackson LR, Koontz JI, Lewis RK, Sun AY, Thomas KL, Bahnson TD, Piccini JP.

Heart Rhythm. 2018 May;15(5):651-657. doi: 10.1016/j.hrthm.2017.12.001. Epub 2017 Dec 6.

PMID:
29222043
26.

Implantable Cardioverter-Defibrillators in Patients With Left Ventricular Assist Devices: On Trial and in Need of a Trial.

Pokorney SD, Al-Khatib SM.

JACC Heart Fail. 2017 Dec;5(12):927-929. doi: 10.1016/j.jchf.2017.09.008. No abstract available.

PMID:
29191300
27.

Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?

Al-Khatib SM, Pokorney SD.

Circulation. 2017 Nov 7;136(19):1781-1783. doi: 10.1161/CIRCULATIONAHA.117.030935. No abstract available.

PMID:
29109194
28.

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL.

Heart Rhythm. 2018 Oct;15(10):e190-e252. doi: 10.1016/j.hrthm.2017.10.035. Epub 2017 Oct 30. No abstract available. Erratum in: Heart Rhythm. 2018 Sep 26;:.

PMID:
29097320
29.

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL.

Heart Rhythm. 2018 Oct;15(10):e73-e189. doi: 10.1016/j.hrthm.2017.10.036. Epub 2017 Oct 30. No abstract available. Erratum in: Heart Rhythm. 2018 Sep 26;:.

PMID:
29097319
30.

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL.

J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220. doi: 10.1016/j.jacc.2017.10.054. Epub 2018 Aug 16. No abstract available. Erratum in: J Am Coll Cardiol. 2018 Oct 2;72(14):1760.

PMID:
29097296
31.

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL.

J Am Coll Cardiol. 2018 Oct 2;72(14):1677-1749. doi: 10.1016/j.jacc.2017.10.053. Epub 2017 Oct 30. No abstract available. Erratum in: J Am Coll Cardiol. 2018 Oct 2;72(14):1756-1759.

PMID:
29097294
32.

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL.

Circulation. 2018 Sep 25;138(13):e210-e271. doi: 10.1161/CIR.0000000000000548. No abstract available. Erratum in: Circulation. 2018 Sep 25;138(13):e415-e418.

PMID:
29084733
33.

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL.

Circulation. 2018 Sep 25;138(13):e272-e391. doi: 10.1161/CIR.0000000000000549. No abstract available. Erratum in: Circulation. 2018 Sep 25;138(13):e419-e420.

PMID:
29084731
34.

Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now?

Al-Khatib SM, Gillis AM, Curtis AB.

Circulation. 2018 Jan 23;137(4):317-319. doi: 10.1161/CIRCULATIONAHA.117.031786. Epub 2017 Oct 25. No abstract available.

PMID:
29070501
35.

Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities.

Zeitler EP, Friedman DJ, Daubert JP, Al-Khatib SM, Solomon SD, Biton Y, McNitt S, Zareba W, Moss AJ, Kutyifa V.

J Am Coll Cardiol. 2017 Oct 17;70(16):2097-2098. doi: 10.1016/j.jacc.2017.07.795. No abstract available.

36.

Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.

Sharma A, Green JB, Dunning A, Lokhnygina Y, Al-Khatib SM, Lopes RD, Buse JB, Lachin JM, Van de Werf F, Armstrong PW, Kaufman KD, Standl E, Chan JCN, Distiller LA, Scott R, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Care. 2017 Dec;40(12):1763-1770. doi: 10.2337/dc17-1091. Epub 2017 Oct 6.

PMID:
28986504
37.

Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-Reply.

Al-Khatib SM, Fonarow GC, Sanders GD.

JAMA Cardiol. 2017 Nov 1;2(11):1283-1284. doi: 10.1001/jamacardio.2017.3221. No abstract available.

PMID:
28975189
38.

New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.

Friedman DJ, Al-Khatib SM, Zeitler EP, Han J, Bardy GH, Poole JE, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD.

Am Heart J. 2017 Sep;191:21-29. doi: 10.1016/j.ahj.2017.06.002. Epub 2017 Jun 9. Review.

39.

The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study.

Hess PL, Al-Khalidi HR, Friedman DJ, Mulder H, Kucharska-Newton A, Rosamond WR, Lopes RD, Gersh BJ, Mark DB, Curtis LH, Post WS, Prineas RJ, Sotoodehnia N, Al-Khatib SM.

J Am Heart Assoc. 2017 Aug 23;6(8). pii: e006103. doi: 10.1161/JAHA.117.006103.

40.

Outcomes Associated With Extraction Versus Capping and Abandoning Pacing and Defibrillator Leads.

Pokorney SD, Mi X, Lewis RK, Greiner M, Epstein LM, Carrillo RG, Zeitler EP, Al-Khatib SM, Hegland DD, Piccini JP.

Circulation. 2017 Oct 10;136(15):1387-1395. doi: 10.1161/CIRCULATIONAHA.117.027636. Epub 2017 Aug 22.

PMID:
28830879
41.

Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II.

Zeitler EP, Al-Khatib SM, Friedman DJ, Han JY, Poole JE, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD.

J Cardiovasc Electrophysiol. 2017 Nov;28(11):1345-1351. doi: 10.1111/jce.13307. Epub 2017 Aug 23.

42.

Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes.

Randolph TC, Hellkamp AS, Zeitler EP, Fonarow GC, Hernandez AF, Thomas KL, Peterson ED, Yancy CW, Al-Khatib SM.

Am Heart J. 2017 Jul;189:48-58. doi: 10.1016/j.ahj.2017.04.001. Epub 2017 Apr 6.

PMID:
28625381
43.

Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.

Zeitler EP, Friedman DJ, Daubert JP, Al-Khatib SM, Solomon SD, Biton Y, McNitt S, Zareba W, Moss AJ, Kutyifa V.

J Am Coll Cardiol. 2017 May 16;69(19):2369-2379. doi: 10.1016/j.jacc.2017.03.531.

44.

2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary.

Writing Committee Members, Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME; ACC/AHA Task Force Members, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Pressler SJ, Wijeysundera DN.

Vasc Med. 2017 Jun;22(3):NP1-NP43. doi: 10.1177/1358863X17701592. Review. No abstract available.

PMID:
28494710
45.

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator.

Al-Khatib SM, Belbase S, Sauro D, Brock G, Brink K, Jackson KP.

HeartRhythm Case Rep. 2016 Aug 17;2(6):478-483. doi: 10.1016/j.hrcr.2016.06.006. eCollection 2016 Nov. No abstract available.

46.

Outcomes Associated With Subcutaneous Implantable Cardioverter Defibrillators-Reply.

Friedman DJ, Al-Khatib SM.

JAMA Cardiol. 2017 Aug 1;2(8):925-926. doi: 10.1001/jamacardio.2017.0304. No abstract available.

PMID:
28403391
47.

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.

Lopes RD, Guimarães PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, Easton JD, Thomas L, Wallentin L, Al-Khatib SM, Held C, Gabriel Melo de Barros E Silva P, Alexander JH, Granger CB, Diener HC.

Blood. 2017 Jun 1;129(22):2980-2987. doi: 10.1182/blood-2016-08-731638. Epub 2017 Mar 29.

48.

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial.

Cowper PA, Sheng S, Lopes RD, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJV, Steg PG, Alexander JH, Wallentin L, Granger CB, Mark DB.

JAMA Cardiol. 2017 May 1;2(5):525-534. doi: 10.1001/jamacardio.2017.0065.

49.

Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.

Al-Khatib SM, Fonarow GC, Joglar JA, Inoue LYT, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD.

JAMA Cardiol. 2017 Jun 1;2(6):685-688. doi: 10.1001/jamacardio.2017.0630.

50.

Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.

Pokorney SD, Mi X, Hammill BG, Allen LaPointe NM, Curtis LH, Al-Khatib SM.

Am J Cardiol. 2017 May 1;119(9):1401-1406. doi: 10.1016/j.amjcard.2017.01.030. Epub 2017 Feb 10.

PMID:
28341360

Supplemental Content

Loading ...
Support Center